Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation

Transplantation

Volumn 83, Issue 7, 2007, Pages 906-911

  Dharancy, Sébastien ^a   Podevin, Philippe ^a   Aoudjehane, Lynda ^a   Batteux, Frédéric ^a   Rosenberg, Arielle R ^b   Soubrane, Olivier ^c   Calmus, Yvon ^a   Conti, Filomena ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c AP HP ^*  (France)

Author keywords

Hepatitis C virus; Interleukin 2; Interleukin 4; Liver transplantation

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADRENAL CORTEX HORMONES; ADULT; BIOPSY; CYCLOSPORINE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-4; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS; TRANSCRIPTION, GENETIC;

EID: 34247578038     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000258729.68871.be     Document Type: Article

References (37)

1. Berenguer M, Lopes-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666.
2. Schluger LK, Sheiner PA, Thung SN, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971.
3. Belli LS, Silini E, Alberti A, et al. Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transpl Surg 1996; 2: 200.
4. Curry MP. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004; 78: 955.
5. Berenguer M, Ferrell L, Watson J, et al. l. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
6. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8: S14.
7. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899.
8. Schirren CA, Jung M, Worzfeld T, et al. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection. Liver Transpl 2000; 6: 222.
9. Bertoletti A, D'Elios MM, Boni C, et al. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112: 193.
10. Napoli J, Bishop GA, McGuinness PH, et al. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759.
11. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348.
12. Lechmann M, Woitas RP, Langhans B, et al. Decrease frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol 1999; 31: 971.
13. Cacciarelli TV, Martinez OM, Gish RG, et al. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alpha. Hepatology 1996; 24: 6.
14. Reiser M, Marousis CG, Nelson DR, et al. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997; 26: 471.
15. Tsai SL, Liaw YF, Chen MH, et al. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25: 449.
16. Zekry A, Bishop GA, Bowen DG, et al. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl 2002; 8: 292.
17. Andersson J, Nagy S, Groth CG, Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 75: 136.
18. Ramierz F, Fowell DJ, Puklavec M, et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156: 2406.
19. Conti F, Calmus Y, Rouer E, et al. Increased expression of interleukin-4 during liver allograft rejection. J Hepatol 1999; 30: 935.
20. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289.
21. Datta Gupta S, Hudson M, Burroughs AK, et al. Grading of cellular rejection after orthotopic liver transplantation. Hepatology 1995; 21: 46.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
23. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219.
24. Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10 year follow-up. Transplantation 2004; 77: 226.
25. Charlton M. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence. Liver Transpl 2003; 9: S58.
26. Chazouilleres O, Kim M, Combs C, et al. Quantification of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994.
27. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999; 30: 595.
28. Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473.
29. Cerny A, Pape GR. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000; 181: 1528.
30. Schirren CA, Jung MC, Gerlach JT, et al. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000; 32: 597.
31. Penna A, Missale G, Lamonca V, et al. Intrahepatic and circulating HLA class II restricted hepatitis C virus specific T cells; functional characterisation in patients with chronic hepatitis C. Hepatology 2002; 35: 1225.
32. Boleslawski E, Conti F, Sanquer S, et al. Evaluation of interleukin-2 expression and anticalcineurin activity in peripheral blood mononuclear cells for monitoring immunosuppressive therapy after liver transplantation. Transplantation 2004; 77: 1815.
33. Lang T, Krams SM, Martinez OM. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation 1996; 62: 776.
34. Chang TT, Young KC, Yang YJ, et al. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection. Hepatology 1996; 23: 977.
35. Tiggelman AM, Boers W, Linthorst C, et al. Collagen synthesis by human liver (myo) fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma. J Hepatol 1995; 23: 307.
36. Cheever AW, Finkelman FD, Cox TM. Anti-interleukin-4 treatment diminishes secretion of Th2 cytokines and inhibits hepatic fibrosis in murine schistosomiasis japonica. Parasite Immunol 1995; 17: 103.
37. McCaughan GW, Zekry A. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 2004; 40: 368.